Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kancera AB (publ)

KAN
Current price
1.65 SEK +0.12 SEK (+7.43%)
Last closed 1.53 SEK
ISIN SE0015658570
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 210 109 682 SEK
Yield for 12 month -51.24 %
1Y
3Y
5Y
10Y
15Y
KAN
21.11.2021 - 28.11.2021

Kancera AB (publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops KAN571, a ROR1 inhibitor for the treatment of mantle cell lymphoma and B-cell malignancy. Kancera AB (publ) was incorporated in 2010 and is headquartered in Solna, Sweden. Address: Karolinska Institutet Science Park, Solna, Sweden, 171 65

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

35.68 SEK

P/E ratio

Dividend Yield

Current Year

+1 043 288 SEK

Last Year

+759 036 SEK

Current Quarter

Last Quarter

Current Year

-1 980 745 SEK

Last Year

+396 149 SEK

Current Quarter

Last Quarter

Key Figures KAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -50 807 776 SEK
Operating Margin TTM 9243.92 %
PE Ratio
Return On Assets TTM -36.57 %
PEG Ratio
Return On Equity TTM -66.39 %
Wall Street Target Price 35.68 SEK
Revenue TTM -596 742 SEK
Book Value 0.69 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 1540.7 %
Dividend Yield
Gross Profit TTM 759 032 SEK
Earnings per share -0.56 SEK
Diluted Eps TTM -0.56 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics KAN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 24.02.2021
Dividend Date

Stock Valuation KAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 367.3777
Price Sales TTM 199.1071
Enterprise Value EBITDA -2.8935
Price Book MRQ 2.5113

Financials KAN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators KAN

For 52 weeks

1.34 SEK 6.82 SEK
50 Day MA 2.03 SEK
Shares Short Prior Month
200 Day MA 2.12 SEK
Short Ratio
Shares Short
Short Percent